Accurate Nonendoscopic Detection of Esophageal Squamous Cell Carcinoma Using Methylated DNA Biomarkers

Esophageal Squamous Cell Carcinoma Consortium

doi:10.1053/j.gastro.2022.04.021

Accurate Nonendoscopic Detection of Esophageal Squamous Cell Carcinoma Using Methylated DNA Biomarkers

Esophageal Squamous Cell Carcinoma Consortium

Research output: Contribution to journal › Short survey › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	507-509.e2
Journal	Gastroenterology
Volume	163
Issue number	2
DOIs	https://doi.org/10.1053/j.gastro.2022.04.021
Publication status	Published - Aug 2022
Externally published	Yes

Access to Document

10.1053/j.gastro.2022.04.021

Cite this

@article{6e47c53255404871bbd84f473ae00d09,

title = "Accurate Nonendoscopic Detection of Esophageal Squamous Cell Carcinoma Using Methylated DNA Biomarkers",

author = "{Esophageal Squamous Cell Carcinoma Consortium} and Ke Ma and Andrew Kalra and Tsai, {Hua Ling} and Samson Okello and Yulan Cheng and Meltzer, {Stephen J.} and Lumori, {Boniface A.E.} and Opio, {Christopher K.} and Simran Jit and Ludmila Danilova and Zhe Wang and Cem Simsek and Saowanee Ngamruengphong and Shin, {Eun Ji} and Khashab, {Mouen A.} and Singh, {Vikesh K.} and Tieu, {Alan H.} and Corey Nolet and Dennis Gong and Chang, {Kai Hua} and Vishnu Prasath and Bollinger, {Robert C.} and Wang, {Tza Huei} and Josephine Feliciano and Lam, {Vincent K.} and Richard Battafarano and Michelle Turner and Peggy Lang and Marrone, {Kristen A.} and Hao Wang",

note = "Funding Information: Conflicts of interests These authors disclose the following: Stephen J. Meltzer is a founder of, and holds equity in, Capsulomics, Inc. Johns Hopkins University School of Medicine owns equity in Capsulomics, Inc. Ke Ma and Yulan Cheng are co-inventors of technology licensed to Capsulomics, Inc. Ke Ma also owns equity in Capsulomics, Inc. Mouen A. Khashab is a consultant for Boston Scientific, Olympus America, Medtronic, Apollo Endosurgery, Pentax, and GI Supply, and receives royalties from UpToDate and Elsevier. Eun Ji Shin is a consultant for Boston Scientific. Vikesh K. Singh is a consultant to Abbvie and Ariel Precision Medicine and a scientific advisory board member to and stock option holder of Kyttaro, received grant funding from Abbvie, Orgenesis, and Theraly. Corey Nolet: Advisor to Capsulomics, Inc. Dennis Gong: Employed by Capsulomics, Inc. The remaining authors disclose no conflicts. Funding Information: Funding This work was supported by grants from the National Institutes of Health (CA211457). Dr Meltzer is an American Cancer Society Clinical Research Professor and the Harry and Betty Myerberg/Thomas R. Hendrix Professor of Gastroenterology. This research was also supported by a generous gift from Peter T. Nicholl. Funding Information: Funding This work was supported by grants from the National Institutes of Health (CA211457). Dr Meltzer is an American Cancer Society Clinical Research Professor and the Harry and Betty Myerberg/Thomas R. Hendrix Professor of Gastroenterology. This research was also supported by a generous gift from Peter T. Nicholl. Conflicts of interests These authors disclose the following: Stephen J. Meltzer is a founder of, and holds equity in, Capsulomics, Inc. Johns Hopkins University School of Medicine owns equity in Capsulomics, Inc. Ke Ma and Yulan Cheng are co-inventors of technology licensed to Capsulomics, Inc. Ke Ma also owns equity in Capsulomics, Inc. Mouen A. Khashab is a consultant for Boston Scientific, Olympus America, Medtronic, Apollo Endosurgery, Pentax, and GI Supply, and receives royalties from UpToDate and Elsevier. Eun Ji Shin is a consultant for Boston Scientific. Vikesh K. Singh is a consultant to Abbvie and Ariel Precision Medicine and a scientific advisory board member to and stock option holder of Kyttaro, received grant funding from Abbvie, Orgenesis, and Theraly. Corey Nolet: Advisor to Capsulomics, Inc. Dennis Gong: Employed by Capsulomics, Inc. The remaining authors disclose no conflicts.",

year = "2022",

month = aug,

doi = "10.1053/j.gastro.2022.04.021",

language = "English",

volume = "163",

pages = "507--509.e2",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Accurate Nonendoscopic Detection of Esophageal Squamous Cell Carcinoma Using Methylated DNA Biomarkers

AU - Esophageal Squamous Cell Carcinoma Consortium

AU - Ma, Ke

AU - Kalra, Andrew

AU - Tsai, Hua Ling

AU - Okello, Samson

AU - Cheng, Yulan

AU - Meltzer, Stephen J.

AU - Lumori, Boniface A.E.

AU - Opio, Christopher K.

AU - Jit, Simran

AU - Danilova, Ludmila

AU - Wang, Zhe

AU - Simsek, Cem

AU - Ngamruengphong, Saowanee

AU - Shin, Eun Ji

AU - Khashab, Mouen A.

AU - Singh, Vikesh K.

AU - Tieu, Alan H.

AU - Nolet, Corey

AU - Gong, Dennis

AU - Chang, Kai Hua

AU - Prasath, Vishnu

AU - Bollinger, Robert C.

AU - Wang, Tza Huei

AU - Feliciano, Josephine

AU - Lam, Vincent K.

AU - Battafarano, Richard

AU - Turner, Michelle

AU - Lang, Peggy

AU - Marrone, Kristen A.

AU - Wang, Hao

N1 - Funding Information: Conflicts of interests These authors disclose the following: Stephen J. Meltzer is a founder of, and holds equity in, Capsulomics, Inc. Johns Hopkins University School of Medicine owns equity in Capsulomics, Inc. Ke Ma and Yulan Cheng are co-inventors of technology licensed to Capsulomics, Inc. Ke Ma also owns equity in Capsulomics, Inc. Mouen A. Khashab is a consultant for Boston Scientific, Olympus America, Medtronic, Apollo Endosurgery, Pentax, and GI Supply, and receives royalties from UpToDate and Elsevier. Eun Ji Shin is a consultant for Boston Scientific. Vikesh K. Singh is a consultant to Abbvie and Ariel Precision Medicine and a scientific advisory board member to and stock option holder of Kyttaro, received grant funding from Abbvie, Orgenesis, and Theraly. Corey Nolet: Advisor to Capsulomics, Inc. Dennis Gong: Employed by Capsulomics, Inc. The remaining authors disclose no conflicts. Funding Information: Funding This work was supported by grants from the National Institutes of Health (CA211457). Dr Meltzer is an American Cancer Society Clinical Research Professor and the Harry and Betty Myerberg/Thomas R. Hendrix Professor of Gastroenterology. This research was also supported by a generous gift from Peter T. Nicholl. Funding Information: Funding This work was supported by grants from the National Institutes of Health (CA211457). Dr Meltzer is an American Cancer Society Clinical Research Professor and the Harry and Betty Myerberg/Thomas R. Hendrix Professor of Gastroenterology. This research was also supported by a generous gift from Peter T. Nicholl. Conflicts of interests These authors disclose the following: Stephen J. Meltzer is a founder of, and holds equity in, Capsulomics, Inc. Johns Hopkins University School of Medicine owns equity in Capsulomics, Inc. Ke Ma and Yulan Cheng are co-inventors of technology licensed to Capsulomics, Inc. Ke Ma also owns equity in Capsulomics, Inc. Mouen A. Khashab is a consultant for Boston Scientific, Olympus America, Medtronic, Apollo Endosurgery, Pentax, and GI Supply, and receives royalties from UpToDate and Elsevier. Eun Ji Shin is a consultant for Boston Scientific. Vikesh K. Singh is a consultant to Abbvie and Ariel Precision Medicine and a scientific advisory board member to and stock option holder of Kyttaro, received grant funding from Abbvie, Orgenesis, and Theraly. Corey Nolet: Advisor to Capsulomics, Inc. Dennis Gong: Employed by Capsulomics, Inc. The remaining authors disclose no conflicts.

PY - 2022/8

Y1 - 2022/8

UR - http://www.scopus.com/inward/record.url?scp=85132828744&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2022.04.021

DO - 10.1053/j.gastro.2022.04.021

M3 - Short survey

C2 - 35483446

AN - SCOPUS:85132828744

SN - 0016-5085

VL - 163

SP - 507-509.e2

JO - Gastroenterology

JF - Gastroenterology

IS - 2

ER -

Accurate Nonendoscopic Detection of Esophageal Squamous Cell Carcinoma Using Methylated DNA Biomarkers

Access to Document

Other files and links

Cite this